2010
DOI: 10.1007/978-90-481-3271-3_4
|View full text |Cite
|
Sign up to set email alerts
|

Islet Cell Development

Abstract: Over the last years, there has been great success in driving stem cells toward insulin-expressing cells. However, the protocols developed to date have some limitations, such as low reliability and low insulin production. The most successful protocols used for generation of insulin-producing cells from stem cells mimic in vitro pancreatic organogenesis by directing the stem cells through stages that resemble several pancreatic developmental stages. Islet cell fate is coordinated by a complex network of inductiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
15
0
1

Year Published

2011
2011
2014
2014

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(17 citation statements)
references
References 105 publications
1
15
0
1
Order By: Relevance
“…Later, the exo-endocrine specification is controlled by the Notch/Hes signaling system, which when active leads, in the exocrine and ductal progenitors and to the suppression of the pro-endocrine factor neurogenin-3, a transcription factor transiently expressed in pancreas, which controls the commitment of multipotent pancreatic endodermal progenitors to the endocrine fate [27], [28]. After the exo-endocrine specification, the endocrine cell differentiation is based on the successive expression of transcription factors which are different for each endocrine cell (for review see [23], [25], [29]. In addition to its early role in the pancreas development, Pdx1 reappears later and intervenes in beta-cell differentiation.…”
Section: Discussionmentioning
confidence: 99%
“…Later, the exo-endocrine specification is controlled by the Notch/Hes signaling system, which when active leads, in the exocrine and ductal progenitors and to the suppression of the pro-endocrine factor neurogenin-3, a transcription factor transiently expressed in pancreas, which controls the commitment of multipotent pancreatic endodermal progenitors to the endocrine fate [27], [28]. After the exo-endocrine specification, the endocrine cell differentiation is based on the successive expression of transcription factors which are different for each endocrine cell (for review see [23], [25], [29]. In addition to its early role in the pancreas development, Pdx1 reappears later and intervenes in beta-cell differentiation.…”
Section: Discussionmentioning
confidence: 99%
“…Endocrine progenitor cells arise via notch/delta signaling in ductal epithelial cells, resulting in their delamination from the epithelium and differentiation into proliferative hormone-producing cells organized as islets [27, 28]. This developmental process, which is initiated on embryonic Day 9.5 (E9.5) in the mouse, is tightly orchestrated by a complex network of transcription factors [28, 29], including neurogenin 3 which plays a central role in specifying the endocrine component [30] (Figure 2).…”
Section: Ctgf/ccn2 In Pancreatic Developmentmentioning
confidence: 99%
“…The prenatal origins and development of β-cells (1,2), the molecular mechanisms of adult β-cell proliferation (3,4), and programmed β-cell death (5) have all been reviewed recently and will not be revisited here. The maintenance and adaptation of β-cell mass after birth involves the addition of new β-cells (6).…”
Section: Origins Of Adult β-Cells and The Regulation Of Adult β-Cell mentioning
confidence: 99%